196
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Obesity reduces methionine sulphoxide reductase activity in visceral adipose tissue

&
Pages 1052-1060 | Received 04 Mar 2011, Accepted 24 May 2011, Published online: 05 Jul 2011

References

  • Prevention USCfDCa. Vital signs: state-specific obesity prevalence among adults – United States, 2009. MMWR Morb Mortal Wkly Rep 2010;951–955.
  • De Flines J, Scheen AJ. Management of metabolic syndrome and associated cardiovascular risk factors. Acta Gastroenterol Belg 2010;73:261–266.
  • Young JB. Diabetes, obesity, and heart failure: the new pandemic. Methodist Debakey Cardiovasc J 2010;6:20–26.
  • McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010;363:2339–2350.
  • Belkina AC, Denis GV. Obesity genes and insulin resistance. Curr Opin Endocrinol Diabetes Obes 2010;17:472–477.
  • Wei EK, Wolin KY, Colditz GA. Time course of risk factors in cancer etiology and progression. J Clin Oncol 2010;28: 4052–4057.
  • Usui C, Asaka M, Kawano H, Aoyama T, Ishijima T, Sakamoto S, Higuchi M. Visceral fat is a strong predictor of insulin resistance regardless of cardiorespiratory fitness in non-diabetic people. J Nutr Sci Vitaminol (Tokyo) 2010;6:109–116.
  • Araki S, Dobashi K, Yamamoto Y, Asayama K, Kusuhara K. Increased plasma isoprostane is associated with visceral fat, high molecular weight adiponectin, and metabolic complications in obese children. Eur J Pediatr 2010;169:965–970.
  • Christiansen T, Paulsen SK, Bruun JM, Pedersen SB, Richelsen B. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. Am J Physiol Endocrinol Metab 2010;298:824–831.
  • Madsen EL, Rissanen A, Bruun JM, Skogstrand K, Tonstad S, Hougaard DM, Richelsen B. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol 2008;158:179–187.
  • Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, . Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114: 1752–1761.
  • Gletsu-Miller N, Hansen JM, Jones DP, Go YM, Torres WE, Ziegler TR, Lin E. Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery. Obesity (Silver Spring) 2009;17:439–446.
  • Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006;70:1437–1442.
  • Curtis JM, Grimsrud PA, Wright WS, Xu X, Foncea RE, Graham DW, . Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes 2010; 59:1132–1142.
  • Singh SP, Niemczyk M, Saini D, Awasthi YC, Zimniak L, Zimniak P. Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice. Biochemistry 2008;47:3900–3911.
  • Grimsrud PA, Picklo MJ, Sr, Griffin TJ, Bernlohr DA. Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell Proteomics 2007;6:624–637.
  • Scherag A, Dina C, Hinney A, Vatin V, Scherag S, Vogel CI, . Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and German study groups. PLoS Genet 2010;6:e1000916.
  • Lindgren CM, Heid IM, Randall JC, Lamina C, Steinthorsdottir V, Qi L, . Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet 2009;5:e1000508.
  • Hotta K, Nakamura M, Nakamura T, Matsuo T, Nakata Y, Kamohara S, . Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1, FTO and MC4R and their effect on visceral fat area in the Japanese population. J Hum Genet 2010; 55:738–742.
  • Lee BC, Gladyshev VN. The biological significance of methionine sulfoxide stereochemistry. Free Radic Biol Med 2011;50: 221–227.
  • Petropoulos I, Mary J, Perichon M, Friguet B. Rat peptide methionine sulphoxide reductase: cloning of the cDNA, and down-regulation of gene expression and enzyme activity during aging. Biochem J 2001;355:819–825.
  • Weissbach H, Resnick L, Brot N. Methionine sulfoxide reductases: history and cellular role in protecting against oxidative damage. Biochim Biophys Acta 2005;1703:203–212.
  • Vougier S, Mary J, Friguet B. Subcellular localization of methionine sulphoxide reductase A (MsrA): evidence for mitochondrial and cytosolic isoforms in rat liver cells. Biochem J 2003; 373:531–537.
  • Lee BC, Dikiy A, Kim HY, Gladyshev VN. Functions and evolution of selenoprotein methionine sulfoxide reductases. Biochim Biophys Acta 2009;1790:1471–1477.
  • Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, . A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008;133: 462–474.
  • Sigalov AB, Stern LJ. Enzymatic repair of oxidative damage to human apolipoprotein A-I. FEBS Lett 1998;433:196–200.
  • Wong YQ, Binger KJ, Howlett GJ, Griffin MD. Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I. Proc Natl Acad Sci USA 2010;107: 1977–1982.
  • Ferrington DA, Sun H, Murray KK, Costa J, Williams TD, Bigelow DJ, Squier TC. Selective degradation of oxidized calmodulin by the 20 S proteasome. J Biol Chem 2001;276:937–943.
  • Brock JW, Jenkins AJ, Lyons TJ, Klein RL, Yim E, Lopes-Virella M, . Increased methionine sulfoxide content of apoA-I in type 1 diabetes. J Lipid Res 2008;49:847–855.
  • Shao B, Cavigiolio G, Brot N, Oda MN, Heinecke JW. Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I. Proc Natl Acad Sci USA 2008;105:12224–12229.
  • Cao G, Lee KP, van der Wijst J, de Graaf M, van der Kemp A, Bindels RJ, Hoenderop JG. Methionine sulfoxide reductase B1 (MsrB1) recovers TRPM6 channel activity during oxidative stress. J Biol Chem 2010;285:26081–26087
  • Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, Stadtman ER. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci USA 2001;98:12920–12925.
  • Salmon AB, Perez VI, Bokov A, Jernigan A, Kim G, Zhao H, Levine RL, Richardson A. Lack of methionine sulfoxide reductase A in mice increases sensitivity to oxidative stress but does not diminish life span. Faseb J 2009;23:3601–3608.
  • Long EK, Rosenberger TA, Picklo MJ, Sr. Ethanol withdrawal increases glutathione adducts of 4-hydroxy-2-hexenal but not 4-hydroxyl-2-nonenal in the rat cerebral cortex. Free Radic Biol Med 2010;48:384–390.
  • Minetti G, Balduini C, Brovelli A. Reduction of DABS-L-methionine-dl-sulfoxide by protein methionine sulfoxide reductase from polymorphonuclear leukocytes: stereospecificity towards the l-sulfoxide. Ital J Biochem 1994;43:273–283.
  • Moskovitz J, Poston JM, Berlett BS, Nosworthy NJ, Szczepanowski R, Stadtman ER. Identification and characterization of a putative active site for peptide methionine sulfoxide reductase (MsrA) and its substrate stereospecificity. J Biol Chem 2000;275:14167–14172.
  • Morton RE, Evans TA. Modification of the bicinchoninic acid protein assay to eliminate lipid interference in determining lipoprotein protein content. Anal Biochem 1992;204: 332–334.
  • Lavine TF. The formation, resolution, and optical properties of the diastereoisomeric sulfoxides derived from L-methionine. J Biol Chem 1947;169:477–491.
  • Uthus EO. Determination of the specific activities of methionine sulfoxide reductase A and B by capillary electrophoresis. Anal Biochem 2010;401:68–73.
  • Altintas MM, Azad A, Nayer B, Contreras G, Zaias J, Faul C, . Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res 2011;52:480–488.
  • Gauthier MS, O'Brien EL, Bigornia S, Mott M, Cacicedo JM, Xu XJ, . Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem Biophys Res Commun 2011;404: 382–387.
  • Dobrian AD, Lieb DC, Ma Q, Lindsay JW, Cole BK, Ma K, . Differential expression and localization of 12/15 lipoxygenases in adipose tissue in human obese subjects. Biochem Biophys Res Commun 2010;403:485–490.
  • Kraunsoe R, Boushel R, Hansen CN, Schjerling P, Qvortrup K, Stockel M, . Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients with morbid obesity. J Physiol 2010;588:2023–2032.
  • Klimcakova E, Roussel B, Marquez-Quinones A, Kovacova Z, Kovacikova M, Combes M, . Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response. J Clin Endocrinol Metab 2011;96:73–82.
  • Zhou HR, Kim EK, Kim H, Claycombe KJ. Obesity-associated mouse adipose stem cell secretion of monocyte chemotactic protein-1. Am J Physiol Endocrinol Metab 2007;293:1153–1158.
  • Harkins JM, Moustaid-Moussa N, Chung YJ, Penner KM, Pestka JJ, North CM, Claycombe KJ. Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J Nutr 2004;134: 2673–2677.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.